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Abstract
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Bioactive lipid mediators derived from n-3 and −6 fatty acids are known to modulate leukocytes.
Metabolic transformation of essential fatty acids to endogenous bioactive molecules plays a major
role in human health. Here we tested the potential of substrates; linoleic acid (LA) and
docosahexaenoic acid (DHA) and their bioactive products; Resolvin-D1(RvD1) and 12-Shydroxyeicosatetraenoic acids(HETE) to modulate macrophage plasticity and cardiac fibroblast
phenotype in presence or absence of lipid metabolizing enzyme 12/15-lipoxygenase(LOX).
Peritoneal macrophages and cardiac fibroblasts were isolated from wild-type (C57BL/6J) and
12/15LOX−/− mice and treated with DHA, LA, 12(S)-HETE), RvD1 for 4,8,12 and 24 h. LA,
DHA, 12(S)-HETE and RvD1 elicited mRNA expression of pro-inflammatory markers Tnf-α,
IL-6, Ccl2 and IL-1β in WT and in 12/15LOX−/− macrophages at early time-point (4h). Bioactive
immunoresolvent RvD1 lowered the levels of Tnf-α, IL-6, and IL-1β at 24 h time-point. Both
DHA and RvD1 stimulated the proresolving markers such as Arg-1, Ym-1, and Mrc-1 in WT
macrophage. RvD1 induced proresolving phenotype Arg-1 expression in both WT 12/15LOX−/−
macrophages even in presence of 12(S)-HETE. RvD1 peaked 5LOX expression in both WT and
12/15LOX−/− at 24 h time-point compared with DHA. RvD1 diminished COX-2 but upregulated
5LOX expression in fibroblast compared with DHA. In summary, the feed-forward enzymatic
interaction with fatty acids substrates and direct mediators (RvD1 and 12(S)-HETE) are
responsive in determining macrophages phenotype and cardiac fibroblast plasticity. Particularly,
macrophages and fibroblast phenotypes are responsive to milieu and RvD1 governs the milieudependent chemokine signaling in presence or absence of 12/15LOX enzyme to resolve
inflammation.
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The importance of differential fatty acids is well-established in many aspects of healthy
immune system of human physiology and cardiovascular health (Patterson et al., 2012);
(Calder, 2017; Halade et al., 2016; Halade et al., 2017; Kain et al., 2017; Lopez et al., 2015;
Yates et al., 2011) Essential fatty acids are transformed using the enzyme lipoxygenases
(LOXs) to form number of endogenous bioactive mediators. Respective bioactive lipid
mediators are derived from the metabolic transformation of long-chain polyunsaturated fatty
acids (n-3 and n-6) in response to injury, infection, stress, or exercise. Fatty acids-derived
mediators are immune responsive and help to initiate and repress inflammation depending
upon the microenvironment at the site of injury (Serhan et al., 2008b) (Halade and Kain,
2017; Kain et al., 2014). The balance of essential fatty acids, such as linoleic acid (LA),
arachidonic acid (AA), and the conditionally essential fatty acids such as docosahexaenoic
(DHA), and eicosapentaenoic acid (EPA), are essential for human health and development
(Zivkovic et al., 2011). Fatty acids are an integral component of membrane biology,
intracellular ion signaling, bioenergetics, energy consumption, and metabolism (Patterson et
al., 2012). Higher content of n-6 fatty acids rather than that of n-3 fatty acid is the common
feature of the western diet. Thus, increased consumption of western diet altered the optimal
balance of n-6 : n-3 ratio which is around 2:1, (Simopoulos, 2001) (Anderson and Ma, 2009)
and now by new estimates, it has increased to the range of 20: 1 (Simopoulos, 2000). An
increased intake omega-6 fatty acid (linoleic acid)-enriched diet stimulates the production of
pro-inflammatory products, such as AA (arachidonic acid), which is subject to oxygenation
by 12/15LOX leading to incidences of diseases involving inflammatory processes. The
diverse array of the metabolic substrate, are utilized by 5-, 12-, and 15LOX enzymes which
insert molecular oxygen into unconjugated double-bond systems via a mechanism that
involves hydrogen abstraction (Schneider et al., 2007). Linoleic acid (LA) gets desaturated
and elongates to AA by Δ6 desaturase and further catalyzed by 12/15LOX, that forms range
of bioactive mediators such as 12(S)- and 15(S)-hydroxyeicosatetraenoic acids (HETE)
known as eicosanoids in injury setting including myocardial infarction (Lee and Blair, 2009;
Lopez et al., 2015). Macrophages specifically peritoneal macrophages are rich source of
eicosanoids (12S)-HETE and 15(S)-HETE derived from the metabolism of arachidonic acid
and play important role in acute inflammation (Scott et al., 1980). Acute inflammation is a
tightly regulated process monitored by mononuclear phagocyte system which includes
monocytes, macrophages, neutrophils and surrounded by collagen secreting myofibroblast.
Macrophages are essential for the initiation, maintenance, and resolution of inflammation
and are activated and deactivated during inflammatory process (Elhelu, 1983) (Fujiwara and
Kobayashi, 2005) and collagen secreting myofibroblast to cover dead tissue area. During this
process, several cellular networks interact via a large number of molecules, such as
neuropeptide, lipid mediators, fibroblast, cytokines and growth factors through leukocytes,
particularly macrophages. To execute and regulate inflammatory response not only immune
cells but resident structural cells such as fibroblast also produces many products such as
growth factors and lipid mediators (Jordana et al., 1994). As fibroblast is the major
component of extracellular matrix (ECM) providing structural tissue integrity, having
powerful inductive effects (Jordana et al., 1994) (Rog-Zielinska et al., 2016). Matrix
associated proteins influence the shape, movement, and state of activation of inflammatory
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cells in the tissue. Thus, fibroblasts being major producers of ECM proteins are linked with
the regulation of inflammatory response (Rog-Zielinska et al., 2016; Van Linthout et al.,
2014).

Author Manuscript

LOXs, specifically 12/15LOX and 5LOX, metabolize n-6 and n-3 fatty acids to produce
bioactive lipid mediators (Kain et al., 2014). Oxygenation step of fatty acids are preceded by
a LOX-mediated pathway, which converts DHA to D-series resolvins (RvD1–6). Immune
responsive resolvin D1 (RvD1, 7S,8R,17S-trihydroxy-4Z,9E,11E,13Z,15E,19Zdocosahexaenoic acid) is a potent anti-inflammatory molecule and is pro-resolving in action
(Saito et al., 2015). Functionally, RvD1 inhibits neutrophil infiltration and promotes
efferocytosis in several disease models, and also promotes the alternative macrophage
phenotype (Kain et al., 2015) (Hsiao et al., 2013) (Lee et al., 2013). In the presented report,
we determine the macrophage and fibroblast chemokine signaling of fatty acids substrate
and specific lipid mediators in the absence and presence of 12/15LOX enzyme. Further, we
expanded the link between 12/15LOX enzyme and fatty acids substrate nexus indicating
both n-3 and n-6 derived lipid mediators govern the macrophage phenotype and cardiac
fibroblast chemokine signaling.

Material and methods
Animal care and compliance

Author Manuscript

8–12-week-old C57BL/6 (wild-type; WT; stock number 000664) and 12/15LOX null mice
from a C57BL/6 genetic background (12/15LOX−/−; stock number 002778) were obtained
from the Jackson laboratory (Bar Harbor, Maine, USA) and were maintained at constant
temperature (19.8–22.2°C). The mice were given free access to water and standard chow
diet. All animals were maintained on a 12-h light, 12-h dark cycle. All protocols involving
animals conformed to the Guide for the Care and Use of Laboratory Animals published by
the US National Institutes of Health (revised 2015) and was approved by the Animal Care
and Use Committee at the University of Alabama at Birmingham.
Materials

Author Manuscript

The following reagents were used in the experiments described below: docosahexaenoic acid
(DHA), linoleic Acid (LA), 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) and resolvin
D1 (RvD1) (Cayman chemicals, Ann Arbor, Michigan). Additional materials used included
Collagenase II (Worthington Biochemical, Lakewood, NJ), DNase I (AppliChem, Ottoweg
Darmstadt), RPMI 1640, and DMEM/F12 media fetal bovine serum (FBS) (Thermo Fischer
Scientific, Grand Island, NY) Bovine serum albumin (BSA; Fraction V; Sigma Aldrich St
Louis, MO) and radio-immunoprecipitation assay (RIPA) lysis buffer (Sigma Aldrich St
Louis, MO). The protease inhibitor cocktail was purchased from Roche GmbH, Germany.
Isolation of peritoneal macrophages
Peritoneal macrophages were isolated from WT and 12/15LOX−/− mice as previously
described (Ma et al., 2013). Briefly, the peritoneal cavity was lavage twice with 10 mL of
ice-cold, RPMI 1640 media with 10% FBS) and 1% antibiotics (Thermo Fischer Scientific,
Grand Island, NY). The recovered media was centrifuged at 250 x g for 10 min. The cell
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pellet was resuspended in 6 mL of RPMI 1640 media. The cells were plated in 6-well plate
(1×106 cells/ well), incubated at 37°C overnight to allow the cells to adhere, and
subsequently washed with fresh media to remove any unattached cells.
Isolation of cardiac fibroblast
Cardiac fibroblasts from WT and 12/15LOX−/− mice were isolated by enzymatic digestion
with 600 U/mL collagenase II and 60 U/mL DNase I. Cells at passage 2 were plated in 6well plates (5×104 cells/well) and allowed to attach at 37°C overnight, then washed using
DMEM/F12 media with 10% FBS and 1% antibiotics to remove unattached cells.
Macrophages and fibroblast treatment

Author Manuscript

Isolated macrophages and fibroblast from WT and 12/15LOX−/− mice were plated in 6 well
plate overnight before treatments. LA, DHA, 12(S)-HETE, and RvD1 was conjugated with
BSA at a maximal concentration of 0.1%. Cultured macrophages were treated with DHA
(50μM), LA (200μM), 12(S)-HETE (100nM) and RvD1 (10ng/ml) for 4 h and 24 h.
Similarly, cultured fibroblast was treated with DHA (50μM), LA (200μM), 12(S)-HETE
(100nM) and RvD1 (10ng/ml) for 4, 8, 12 and 24 h. 0.1% BSA is used as a vehicle control
(VC) and cells without any treatment are used as control (C).
Measurements of macrophage phenotype using Real-Time quantitative PCR

Author Manuscript

For qPCR, reverse transcription was performed with 2.5μg of total RNA using the
SuperScript® VILO cDNA Synthesis Kit (Invitrogen, CA, USA). Quantitative PCR for Tnfα, IL-6, ccl2, IL-1β, Arg-1, Mrc-1 and Ym-1 genes was performed using TaqMan probes
(Applied Biosystems, CA, USA) on a master cycler (ABI, 7900HT, Grand Island, NY). The
mRNA expression was normalized with the reference genes (β-Actin). The results were
reported as 2-ΔCt (ΔΔCt) values. All the experiments were performed in triplicates.
Preparation of protein lysates

Author Manuscript

Cultured macrophages and fibroblast protein lysates were prepared using RIPA lysis buffer
and protease inhibitor cocktail. Briefly, the medium was removed from cells and washed
with cold 1x PBS. Cells were gently scraped in 1X cold PBS and centrifuged at 4oC for 2
min at 14000 rpm. The supernatant was discarded, and the cell pellet was resuspended in
RIPA lysis with a 1X protease inhibitor and incubated on ice for 20 min. The solution was
then centrifuged for 20 min at 4oC at 14000 rpm. The supernatant was collected in fresh
tubes and snap frozen until further use. Protein concentration in each sample was determined
using 1X Bradford protein assay kit according to the manufacturer’s instructions (Bio-Rad,
Hercules, CA, USA) with bovine serum albumin (BSA-2mg/ml) as a standard.
Immunoblotting
Immunoblotting was used to quantify the protein levels in peritoneal macrophages and
cardiac fibroblast. The samples were resolved on criterion XT bis-tris 4–12% 18 well (BioRad Inc. Hercules, California) gel and MOPs Buffer (Bio-Rad, Hercules, California). The
kaleidoscope precision plus standard (Bio-Rad) was used to determine the molecular weight
of the protein for immunoblotting, 10–15 μg of protein lysate per sample was denatured and
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resolved by using criterion XT bis-tris 4–12% 18-gel (Bio-Rad I, Hercules, California.) gel
in MOPs Buffer (Bio-Rad)., then transferred to a nitrocellulose membrane (Bio-Rad,
Hercules, California), and blocked with 5% nonfat milk. The membrane was probed with
COX-2 (1:1000) and 5LOX (1:200) overnight at 4˚C, followed by secondary antibody (BioRad, Hercules, California). The proteins were detected using the Femto chemiluminescence
detection system (Pierce Chemical, Rockford, IL). Densitometry was performed using
Image J software (NIH, USA).
Immunofluorescence

Author Manuscript

The peritoneal macrophages were plated in a 12-well plate (1×106 cells/ well) on coverslips,
incubated at 37°C overnight to allow the cells to adhere, and subsequently washed with fresh
media to remove any unattached cells. The cells were treated with DHA (50μM and RvD1
(10ng/ml) for 24 h for Tnf-α expression. The cells were treated with 12(S)-HETE (100μM
and RvD1 (10ng/ml) for 4 h for Arg-1 and F4/80 expression. Isolated cardiac fibroblast was
plated on Millicell® cell culture inserts (Millipore). Cardiac fibroblast was differentiated into
myofibroblast by treating them to 15ng/ml Tgf-β (15ng/ml) and co-incubated with 12(S)HETE for 18 hr. Cells (peritoneal macrophages or cardiac fibroblast) were fixed using 4%
PFA (paraformaldehyde), permeabilized using 0.1% Triton and blocked for 1hr in 10% goat
serum. Peritoneal macrophages were subsequently incubated with anti-TNF-α- antibody,
Arg-1 and F4/80 (Abcam, Cambridge, MA) overnight and probed with an Alexa-488,
Alexa-55 secondary antibody (Molecular probe), each for 60 min at room temperature.
Cardiac fibroblast was probed with anti-smooth muscle actin-α (SMA-α) antibody (Sigma
Aldrich St Louis, MO) overnight and further probed with Alexa-55 secondary antibody for 1
hr. The nucleus in both cell types was stained using Hoechst (molecular probe). Cells were
mounted using anti-fade mounting media (Thermo Fisher Scientific, Grand Island, NY) and
then visualized and photographed using Nikon A1 high-speed laser confocal microscope.

Author Manuscript

Statistical analysis
Data are expressed as mean ±SEM. Statistical analyses were performed using GraphPad
Prism 5. Two way-analysis of variance (ANOVA) was for multiple comparisons. For 2
groups comparison, student-t-test (unpaired) was applied and p<0.05 was considered as
statistically significant.

Results
RvD1 possesses high potential than DHA in limiting pro-inflammatory cytokines in the
absence of 12/15LOX

Author Manuscript

This study aimed to investigate whether fatty acids substrate (LA compared to DHA) or
respective immune responsive metabolite (12(S)-HETE compared to RvD1) are inducer or
repressor of the macrophage phenotype (proinflammatory or proresolving). After coculturing macrophages with substrate (LA or DHA) and respective metabolites (12(S)HETE or RvD1) secreted Tnf-α, IL-6, Ccl2 and IL-1β cytokines in both WT and 12/15
LOX-/−. In comparison to control cells, there was increase in Tnf-α, IL-6, Ccl2 and IL-1β at
4 h and 24 h after treatment with LA, 12(S)-HETE, DHA, or RvD1 (Figure 1 A-D). Proinflammatory cytokine levels such as Tnf-α, IL-6, and IL-1β remained elevated with LA and
J Cell Physiol. Author manuscript; available in PMC 2020 April 01.
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12(S)-HETE treatment in WT and 12/15LOX-/ - at 24h, but DHA and RvD1 lowered Tnf-α,
IL-6 and IL-1β at 24 h in WT macrophages (Figures 1A-D). The levels of Ccl2 expression in
macrophages remained elevated in RvD1 treated macrophages for both WT and
12/15LOX-/−. RvD1 induced lower level of Tnf-α expression compared with DHA in WT
macrophages provided in supplementary figure 1. The RvD1 limited stimulation of Tnf-α,
IL-6, and IL-1β in 12/15LOX−/− macrophages compared with DHA. Our results indicated
that specific substrate (LA vs DHA) and substrate-derived product (RvD1 and 12(S)-HETE)
are essential in determining the macrophage phenotype in time-dependent manner. RvD1
inhibited the prolonged inflammatory cytokines in the absence of 12/15LOX enzyme while
DHA has limited long-term effect to control prolonged inflammatory phase in the absence of
12/15LOX.
RvD1 polarized macrophages towards resolving phenotype than DHA and LA

Author Manuscript
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Tissue specific macrophage diversity and macrophage role in acute versus chronic
inflammation is active area of investigation (Bronte and Pittet, 2013). For simplicity, proresolving macrophage phenotype referred as M2/alternative or resolving macrophages. Our
previous, in-vivo study of cardiac healing has shown that the M2 macrophages are essential
in controlling the inflammation as they are reparative in action and inhibits their M1
counterparts (Kain et al., 2015; Ma et al., 2013). In-vivo, the concept of M1 and M2 is more
heterogenous and complex. Thus we applied in-vitro approach to understand the role of
12/15LOX and substrate-metabolite nexus. For this, we isolated peritoneal macrophages and
treated them with substrates (LA and DHA) and metabolites (12(S)-HETE and RvD1). From
above results, at 24 h time point, RvD1- but not the DHA was effective in shortening the
pro-inflammatory phase. We further evaluated the effect of LA, 12(S)-HETE, DHA and
RvD1 on the pro-resolving macrophage markers Arg-1, Ym-1 and Mrc-1/CD206 (Figure
2A). Both LA and 12(S)-HETE had limited effect of pro-resolving macrophages markers
such as Ym-1 and Mrc-1, in WT and 12/15LOX−/− at 4 h and 24 h time-point. LA and
12(S)-HETE treated 12/15LOX−/− macrophages lowered expression of Arg-1 compared with
WT macrophages at 24 h time point. Both DHA and RvD1 induced higher levels of Arg-1,
Ym-1 and Mrc-1 expression in WT macrophages indicating pro-resolving phenotype at 24 h.
LA showed the minimal effect on macrophage phenotype in presence or absence of
12/15LOX enzyme. Of note, RvD1 was able to induce pro-resolving phenotype in both WT
and 12/15LOX−/− macrophages. These results indicate that both DHA and DHA-derived
RvD1 were able to induce the macrophages towards pro-resolving phenotype.
RvD1 induced 5LOX expression and stabilized COX-2 in peritoneal macrophages

Author Manuscript

Since, immune responsive RvD1 displayed a higher capacity than DHA to polarize
macrophages towards the reparative phenotype, we further determined, the effect of RvD1
and DHA on the 5LOX and COX-2 expression. Both LA and 12(S)-HETE were used as
negative and positive controls respectively. Our results showed that LA, 12(S)-HETE, RvD1,
and DHA were able to induce COX-2 expression in both WT and 12/15LOX−/−
macrophages. However, no significant difference was observed in COX-2 expression with
respective treatments (Figures 2B and Figures 2C). RvD1 treatment displayed 2.1 fold
increase in 5LOX expression compared with DHA, 12(S)-HETE, and LA in WT
macrophages at 24 h. Treatment with RvD1 induced higher expression of 5LOX in
J Cell Physiol. Author manuscript; available in PMC 2020 April 01.
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12/15LOX−/− macrophages compared with WT. However, there was no difference in the
5LOX expression levels in macrophages treated with LA, 12(S)-HETE, RvD1 and DHA
(Figures 2B and Figures 2C). The data indicates RvD1 potentially stabilizes macrophages
towards in reparative mode.
12(S)-HETE stimulated early induction of COX-2 and 5LOX in cardiac fibroblast in the
absence of 12/15LOX
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Induction of COX-2 gene in response to 12(S)-HETE has been well demonstrated in
different cell types and is responsible for forming the proinflammatory microenvironment
(Sun et al., 2015). We further evaluated the impact of 12(S)-HETE on both proinflammatory COX-2 and pro-resolving 5LOX in WT and 12/15LOX−/− cardiac fibroblast.
12(S)-HETE induce COX-2 expression in WT and 12/15LOX−/− cardiac fibroblast, however,
12/15LOX−/− cardiac fibroblast displayed early induction of COX-2 at 4h time point
compared with WT-cardiac fibroblast (Figures 3A and Figures 3B).In the absence of
12/15LOX, cardiac fibroblast displayed higher expression 5LOX compared with WT cardiac
fibroblast that was increased in a time-dependent manner. The expression of 5LOX reached
to its peak (~4.1 fold) at 24 h of time-point in 12/15LOX−/− cardiac fibroblast compared
with WT cardiac fibroblast (Figures 3A and Figures 3C). 12/15LOX and respective
metabolite plays important in fibrosis. Since, presence of 12(S)-HETE activates
inflammatory signal, we further delineated impact of 12(S)-HETE on myofibroblast
differentiation in presence and absence of 12/15LOX. We induced myofibroblast transdifferentiation using tgf-β (15ng/ml) in cardiac fibroblast isolated from WT and 12/15LOX
−/− mice. Differentiation of fibroblast to myofibroblast phenotype was characterized by
expression of smooth muscle actin (SMA) (Rohr, 2009). Control WT and 12/15LOX−/−
cardiac fibroblast displayed showed lower expression of SMA. 12/15-LOX−/− cardiac
fibroblast showed limited tgf-β induced trans-differentiation of myofibroblast indicated by
decrease in SMA expression Treatment with 12(S)-HETE induced SMA expression in both
WT- and 12/15LOX−/− -cardiac fibroblast. However, 12/15LOX−/− cardiac fibroblast
displayed lower level of SMA compared with WT. Combined treatment of tgf-β and 12(S)HETE in cardiac fibroblast limited SMA expression in both WT and 12/15LOX−/− mice.
Interestingly, overall level of SMA was lower is 12/15LOX−/− cardiac fibroblast (Figure
3D). Thus, in-vitro data using naïve fibroblast confirms that 12/15LOX deletion limits
fibroblast to myofibroblast transition that supports our in-vivo findings in cardiac
remodeling (Kain et al., 2018).
RvD1 but not DHA diminished expression of COX-2 in 12/15LOX−/− cardiac fibroblast

Author Manuscript

Inflammation and fibrosis are consecutive and inter-related conditions with many
overlapping mechanisms. Cardiac fibroblasts activation is an essential step in maintaining
the extracellular matrix in the normal heart and their coordination with macrophages is
essential in response to injury to reduce inappropriate fibrotic response (Rog-Zielinska et al.,
2016). Thus, we further elucidated how substrates; LA and DHA or respective products;
12(S)-HETE and RvD1 impacts COX-2 expression in cardiac fibroblast. We treated cardiac
fibroblast with RvD1, LA or DHA in a time-dependent manner for 4, 8, 12 and 24 h. RvD1
treated WT and 12/15LOX−/− cardiac fibroblast displayed an early induction of COX-2,
which diminished at 12 h and 24 h of time point (Figures 4A and Figures 4B, upper panel).
J Cell Physiol. Author manuscript; available in PMC 2020 April 01.
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However, the COX-2 was re-induced in 12/15LOX−/− cardiac fibroblast at 24 h (Figure 4B,
upper right panel). LA treated cardiac fibroblast displayed stable COX-2 expression in WT
and 12/15LOX−/− cardiac fibroblast from 4 h to 24 h (Figure 4A and Figure 4B, middle
panel). DHA treated cardiac fibroblast also showed early induction of COX-2 in both WT
and 12/15LOX−/−, but was diminished at 24 h in WT cardiac fibroblast. The COX-2 was
continuously expressed in 12/15LOX−/−cardiac fibroblast (Figures 4A and Figures 4B, lower
panel). The results displayed that RvD1 modulated the COX-2 expression in time-dependent
manner, indicating diversified feed-forward loop interactions in the microenvironment.
RvD1 but not DHA induced expression of 5LOX in cardiac fibroblast

Author Manuscript

To investigate, whether RvD1 and DHA can induce 5LOX expression in cardiac fibroblast in
similar manner to the peritoneal macrophages, we treated cardiac fibroblast with RvD1, LA
or DHA in a time-dependent manner. 5LOX was induced in RvD1 treated fibroblast, in a
time-dependent manner and reached to its peak expression at 24 h in WT (Figure 4C, upper
left panel). Both LA and DHA failed to induce 5LOX in WT-CF (Figure 4C, middle and
lower left panel). 5LOX was basally expressed in 12/15LOX−/− cardiac fibroblast compared
with WT cardiac fibroblast. The 5LOX expression was not impacted in 12/15LOX−/− cardiac
fibroblast treated with RvD1, LA, or DHA (Figure 4D). Overall data indicated RvD1
influenced 5LOX in presence of 12/15LOX enzyme.
RvD1 stimulates expression of proresolving Arg-1 in combination with 12(S)-HETE in
macrophages
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Despite the presence of detectable IL-6, TNF-α, IL-1β or Ccl2 for 4 h treatment of RvD1 in
peritoneal macrophages either in presence or absence of 12/15LOX, we noted that the Arg-1
mRNA was higher in macrophages treated with RvD1. Therefore, we next determined how
the combination of 12(S)-HETE with RvD1 will impact Arg-1 expression. To evaluate
former, naïve peritoneal macrophages were isolated from WT and 12/15LOX−/− mice and
were treated independently with RvD1, 12(S)-HETE and combination of RvD1, 12(S)HETE. The change in expression of Arg-1 (red) along with F4/80 (green) was monitored
over time by immunofluorescence. Untreated 12/15LOX−/− macrophages displayed higher
basal expression of Arg-1 compared to WT control macrophages (Figure 5A, first panel). In
contrast 12(S)-HETE treated WT macrophages, did not displayed any change in Arg-1
expression. There was a decrease in Arg-1 expression in 12/15LOX−/− macrophages treated
with 12(S)-HETE compared to 12/15LOX−/− untreated macrophages (Figure 5A, second
panel). Interestingly, RvD1 treatments lead to increase in expression of Arg-1 as well as of
F4/80 in both WT and 12/15LOX−/− macrophages (Figure 5A, third panel). Combination of
12(S)-HETE and RvD1 consistently expressed Arg-1 among both WT and 12/15LOX−/−
macrophages in vitro (Figure 5A, fourth panel). Together, our data demonstrate that RvD1
stimulates Arg-1 expression independent of 12/15LOX leading to alternative activation of
primary macrophages.

Discussion
Non-resolving and overactive inflammation is the major driver of cardiac disease pathology
and impaired leukocyte directed cellular and molecular healing (Halade et al., 2018; Kain et
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al., 2018 ; Kain et al., 2014; Lopez et al., 2015). Further, cellular membrane integrity with an
optimum balance of fatty acids is important for many physiological and pathological events
(Mills et al., 2005). Both n-6 (LA) and n-3 fatty acids (DHA) act as metabolic substrates for
fat busting lipoxygenases enzymes which results in the production of series of bioactive lipid
mediators (Calder, 2010). LOX-derived bioactive mediators and eicosanoids have a diverse
role in modulating cellular function and phenotypes depending on the fatty acids substrate
and microenvironment (Buckley et al., 2014). The present study evaluated the impact of the
substrate such as DHA or LA and their metabolic product such as RvD1 or 12(S)-HETE, on
macrophage plasticity and fibroblast phenotype in presence and absence of enzyme
12/15LOX that are critical in immune responsive process. The major outcomes are; 1) n-3
product RvD1 is more potent than its substrate DHA in limiting proinflammatory
macrophages phentopye and promoting pro-resolving macrophages phenotype in the
absence of 12/15LOX; 2) RvD1 but not DHA stabilized the expression of 5LOX in both
macrophages and cardiac fibroblast, and 4) 12(S)-HETE leads to early induction of COX-2
and 5LOX and led to myofibroblast transdifferentian in cardiac fibroblast in the absence of
12/15LOX (Figure 5B).

Author Manuscript
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Macrophages are essential effector cells which are involved in wound healing and tissue
regeneration. Macrophages are major producer of TGF-β, considered the most significant
pro-fibrotic agent involved fibrotic response. The macrophages play a complex role in
fibrosis via interacting with fibroblast by producing chemokines and cytokines (Van
Linthout et al., 2014). Further, incessant production of lipid mediator or cytokines from
macrophages creates resolving or non-resolving chronic inflammatory milieu leading to
disease pathology (Halade et al., 2018; Kain et al., 2018; Kain et al., 2014). Several
inhibitors are synthesized to inhibit the inflammatory cytokines to treat several nonresolving inflammatory disease pathology or chronic inflammation (Chung et al., 2003)
(Listing et al., 2008). Both RvD1 and DHA are known to inhibit the expression of
inflammatory cytokines in macrophages and in many animal models (Liu et al., 2012) (Kain
et al., 2015) (Ali et al., 2016). Fatty acid busting 12/15LOX enzyme utilizes DHA as a
substrate and metabolizes into the several bioactive products. These bioactive products serve
in important anti-inflammatory and pro-resolving effects, including airway and glomerular
inflammation as well as atherosclerosis (Zivkovic et al., 2011) (Nordgren et al., 2014)
(Chang and Deckelbaum, 2013). Exposure to DHA inhibits the production of
proinflammatory cytokines and chemokines such as IL-6, Tnf-α, Ccl-2, and IL-1β in
macrophages. The genetic deletion of 12/15LOX reduces the long-term potency of DHA to
inhibit proinflammatory cytokines and chemokines in macrophages. However, the RvD1
inhibited proinflammatory cytokines in presence well as absence of 12/15LOX indicating
that the RvD1 is more active than DHA in modulating macrophage phenotype towards
proresolving phenotype but 12(S)-HETE displayed early proinflammatory trend, in both the
presence and absence of 12/15LOX. Fatty acids substrate and respective metabolites have
diverse cellular targets in the healing response, including leukocytes, endothelial cells,
fibroblasts, platelets, and smooth muscle cells (Serhan et al., 2008a).
Homeostatic level, LA or DHA are the substrates of membrane integrity, and LOXinteraction modulates cytokine production in cells and tissues indicating their direct role in
creating the microenvironment (Nathan and Sporn, 1991). Substrate-enzyme interaction
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defines the microenvironment post-injury having both contextual positive and negative
impacts and depends on where and when the bioactive mediators are produced in the
biological system (Dalli and Serhan, 2016). Thus, cytokines are diversified depending upon
the chemokine signal they programs cells constitutively, or incidentally. Incidental
programming includes inflammatory response, healing, and repair. Similar to cytokines,
lipid mediators or classical eicosanoids are the class of chemical molecules which are
similar in function to cytokines and widely as “chemokines in context.” The immune
responsive bioactive molecules like RvD1 belongs to similar category possessing proresolving actions different than anti-inflammatory and are considered to work as endogenous
“decelerating signals” for inflammation by polarizing macrophages toward the pro-resolving
phenotype (M2) (Kain et al., 2015) (Kain et al., 2014) (Kang and Lee, 2016). In the current
study, we evaluated the impact of substrate DHA and bioactive RvD1, LA and 12(S)-HETE
in determining macrophages phenotype. Both DHA and RvD1 caused a significant increase
in expression of Arg-1, Ym-1, and Mrc-1 indicating pro-resolving macrophage phenotypic
profile. The treatment of 12(S)-HETE did not express any pro-resolving phenotype in
macrophages, indicating that 12(S)-HETE is more efficient in advancing towards
proinflammatory milieu. In the absence of 12/15LOX, DHA lose properties to polarize
macrophages towards pro-resolving phenotype; however, it did not impact RvD1 potential.
Taken together, our data demonstrate that the pro-resolving bioactive RvD1 modulates
macrophage and fibroblast culture milieu towards resolving phenotype in the absence of
12/15LOX enzyme. In contrast, based on provided in-vitro results, the pro-resolving
properties of substrate DHA are more dependent on the availability of enzyme 12/15LOX.
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Eicosanoids are generated by three separate enzyme families, lipoxygenases (LOX),
cyclooxygenases (COX) and cytochrome P450 (CYP), which catalyze lipid peroxidation in a
stereo- and regio-specific manner (Hammond and O’Donnell, 2012). Among them, lipid
busting enzymes 5LOX and COX-2 are the potent biocatalyst for the generation of lipid
mediators leukotrienes and prostaglandins respectively (Poeckel and Funk, 2010) (Ricciotti
and FitzGerald, 2011). Fatty acid (n-6)-derived leukotrienes and prostaglandins are essential
to initiate a physiological acute inflammatory response which successfully resolve and repair
tissue damage. Both DHA and RvD1 were able to induce COX-2 and 5LOX expression in
macrophages and fibroblast. In the absence of 12/15LOX, RvD1 reduced the COX-2
expression in cardiac fibroblast in time-dependent manner, but DHA had limited potential.
Similarly, 12(S)-HETE displayed the early induction of COX-2 and 5LOX in the absence of
12/15LOX which remained persistent at later time points. Our results showed that RvD1
potentially modulate both 5LOX and COX-2 expression depending on the cell type while
DHA had minimal ability to do so, indicating the contextual nature of substrate-COX/LOX
interaction.
The anti-inflammatory and pro-resolving actions of substrate DHA and RvD1 are well
demonstrated in in-vitro, ex-vivo and in-vivo for different disease pathology (Ali et al.,
2016; Chen et al., 2005; Halade et al., 2010; Kain et al., 2015; Saito et al., 2015;
Vasconcelos et al., 2015). Our study highlighted the proresolving properties of the bioactive
metabolic product RvD1 are different from its substrate molecule DHA in modulating the
macrophages phenotype. Further, our study also provides an important insight that like
cytokines, RvD1 is immuno-resolvent and acts contextually. RvD1 possess potent
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immunomodulating properties and is a potential candidate for therapeutics in inflammatory
diseases.
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Figure1: RvD1 effectively control pro-inflammatory macrophages phenotypes in the absence of
12/15LOX, compared to DHA.
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WT and 12/15LOX−/− peritoneal macrophages treated with LA (200μ), 12(S)-HETE
(100nM), DHA(50μM) and RvD1(10ng/ml) for 4h and 24 h. mRNA expression of classical
M1 markers A. Tnf-α B. IL-6 C. Ccl2 D. IL-1β. Expression levels are normalized to
HPRT-1. *p<0.05 vs. untreated cells, $p<0.05 vs. treated WT cells. Results are presented as
mean±SEM. Data are representative of a n=3 independent experiments.
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Figure 2: RvD1 is potent than DHA in polarizing macrophages towards reparative phenotype.
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WT and 12/15LOX−/− peritoneal macrophages treated with LA (200μM), 12(S)-HETE
(100nM), DHA (50μM) and RvD1 (10ng/ml) for 4h and 24 h. mRNA expression of
alternative M2 markers A Arg-1, Ym-1, Mrc-1/CD206. Expression levels are normalized to
HPRT-1. B WT and 12/15LOX−/− peritoneal macrophages treated with DHA(50μM),
RvD1(10ng/ml), LA(200μM), and 12(S)-HETE(100nM) for 24h. Immunoblot representing
COX-2 and 5LOX expression. CDensitometric analysis of COX-2 and 5LOX in LA, 12(S)HETE, DHA and RvD1 treated peritoneal macrophages at 4 h and 24 h.*p<0.05 vs untreated
cells, $p<0.05 vs. treated WT cells. Results are presented as mean±SEM. Data are
representative of a n=3 independent experiments.
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Figure 3: 12(S)-HETE promotes early induction of COX-2 and 5LOX in cardiac fibroblast and
trans-differentiation of fibroblast to myofibroblast.

Author Manuscript

Cardiac fibroblast treated with 12(S)-HETE (100nM) for 4, 8, 12 and 24 h. A Immunoblot
representing COX-2 and 5LOX expression in WT and 12/15LOX−/− cardiac fibroblast
treated with in 12(S)-HETE. B Densitometric analysis of COX-2 levels. C Densitometric
analysis of 5LOX levels. *p<0.05 vs untreated cells, $p<0.05 vs. treated WT cells. Results
are presented as mean ± SEM. Data are representative of a n=3 independent experiments. D
Representative immunofluorescence images representing α-SMA expression (Red) and
Hoechst (blue) in cardiac fibroblast isolated from WT and 12/15LOX−/− with and without
treatment of Tgf-β (15ng/ml) and 12(S)-HETE (100nM) for 18 h. Data are representative of
n=3 independent experiments.
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Figure 4: Prolonged exposure of RvD1 limited COX-2 and 5LOX expression in cardiac fibroblast
compared with DHA and LA.

Immunoblot representing A COX-2 expression in WT-cardiac fibroblast B COX-2
expression in 12/15LOX−/−-cardiac fibroblast C 5LOX expression in WT-cardiac fibroblast
D 5LOX expression in 12/15LOX−/−-cardiac fibroblast treated with in RvD1(10ng/ml),
LA(200μM), and DHA (50μM) at 4 h, 8 h,12 h and 24 h. Data are representative of a n=3
independent experiments.
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Figure 5: RvD1 stimulates Arg-1 expression in peritoneal macrophages independent of
12/15LOX-/.

A -Representative immunofluorescence images representing Arg-1 (red), F4/80 (green)
expression and Hoechst (blue) in peritoneal macrophages isolated from WT and 12/15LOX
−/− mice treated with 12(S)-HETE (100nM), RvD1 (10ng/ml) and combination of 12(S)HETE and RvD1. Data are representative of n=2 independent experiments. B Figure
illustrating the enzymatic interaction of fatty acids and respective products determine the
macrophage phenotype and diversified inflammation-resolution milieu.
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